98 related articles for article (PubMed ID: 36599922)
21. Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity.
Zhang R; Tu J; Liu S
Semin Cancer Biol; 2022 Jul; 82():11-25. PubMed ID: 33737107
[TBL] [Abstract][Full Text] [Related]
22. RAC1 plays an essential role in estrogen receptor alpha function in breast cancer cells.
Sun J; Gaidosh G; Xu Y; Mookhtiar A; Man N; Cingaram PR; Blumenthal E; Shiekhattar R; Goka ET; Nimer SD; Lippman ME
Oncogene; 2021 Oct; 40(40):5950-5962. PubMed ID: 34373577
[TBL] [Abstract][Full Text] [Related]
23. RAC1B modulates intestinal tumourigenesis via modulation of WNT and EGFR signalling pathways.
Gudiño V; Pohl SÖ; Billard CV; Cammareri P; Bolado A; Aitken S; Stevenson D; Hall AE; Agostino M; Cassidy J; Nixon C; von Kriegsheim A; Freile P; Popplewell L; Dickson G; Murphy L; Wheeler A; Dunlop M; Din F; Strathdee D; Sansom OJ; Myant KB
Nat Commun; 2021 Apr; 12(1):2335. PubMed ID: 33879799
[TBL] [Abstract][Full Text] [Related]
24. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
25. RAC1 Takes the Lead in Solid Tumors.
De P; Aske JC; Dey N
Cells; 2019 Apr; 8(5):. PubMed ID: 31027363
[TBL] [Abstract][Full Text] [Related]
26. Integrin-Rac signalling for mammary epithelial stem cell self-renewal.
Olabi S; Ucar A; Brennan K; Streuli CH
Breast Cancer Res; 2018 Oct; 20(1):128. PubMed ID: 30348189
[TBL] [Abstract][Full Text] [Related]
27. TSVdb: a web-tool for TCGA splicing variants analysis.
Sun W; Duan T; Ye P; Chen K; Zhang G; Lai M; Zhang H
BMC Genomics; 2018 May; 19(1):405. PubMed ID: 29843604
[TBL] [Abstract][Full Text] [Related]
28. Relevance of small GTPase Rac1 pathway in drug and radio-resistance mechanisms: Opportunities in cancer therapeutics.
Cardama GA; Alonso DF; Gonzalez N; Maggio J; Gomez DE; Rolfo C; Menna PL
Crit Rev Oncol Hematol; 2018 Apr; 124():29-36. PubMed ID: 29548483
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic sensitivity to Rac GTPase inhibition requires consequential suppression of mTORC1, AKT, and MEK signaling in breast cancer.
Hampsch RA; Shee K; Bates D; Lewis LD; Désiré L; Leblond B; Demidenko E; Stefan K; Huang YH; Miller TW
Oncotarget; 2017 Mar; 8(13):21806-21817. PubMed ID: 28423521
[TBL] [Abstract][Full Text] [Related]
30. The requirement of integrins for breast epithelial proliferation.
Moreno-Layseca P; Ucar A; Sun H; Wood A; Olabi S; Gilmore AP; Brennan K; Streuli CH
Eur J Cell Biol; 2017 May; 96(3):227-239. PubMed ID: 28363396
[TBL] [Abstract][Full Text] [Related]
31. Rho GTPases: Regulation and roles in cancer cell biology.
Haga RB; Ridley AJ
Small GTPases; 2016 Oct; 7(4):207-221. PubMed ID: 27628050
[TBL] [Abstract][Full Text] [Related]
32. Rac1 Controls Both the Secretory Function of the Mammary Gland and Its Remodeling for Successive Gestations.
Akhtar N; Li W; Mironov A; Streuli CH
Dev Cell; 2016 Sep; 38(5):522-35. PubMed ID: 27623383
[TBL] [Abstract][Full Text] [Related]
33. Rac1 in human diseases: The therapeutic potential of targeting Rac1 signaling regulatory mechanisms.
Marei H; Malliri A
Small GTPases; 2017 Jul; 8(3):139-163. PubMed ID: 27442895
[TBL] [Abstract][Full Text] [Related]
34. RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment.
Hein AL; Post CM; Sheinin YM; Lakshmanan I; Natarajan A; Enke CA; Batra SK; Ouellette MM; Yan Y
Oncogene; 2016 Dec; 35(49):6319-6329. PubMed ID: 27181206
[TBL] [Abstract][Full Text] [Related]
35. Deregulation of Rho GTPases in cancer.
Porter AP; Papaioannou A; Malliri A
Small GTPases; 2016 Jul; 7(3):123-38. PubMed ID: 27104658
[TBL] [Abstract][Full Text] [Related]
36. Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity.
Simões BM; O'Brien CS; Eyre R; Silva A; Yu L; Sarmiento-Castro A; Alférez DG; Spence K; Santiago-Gómez A; Chemi F; Acar A; Gandhi A; Howell A; Brennan K; Rydén L; Catalano S; Andó S; Gee J; Ucar A; Sims AH; Marangoni E; Farnie G; Landberg G; Howell SJ; Clarke RB
Cell Rep; 2015 Sep; 12(12):1968-77. PubMed ID: 26387946
[TBL] [Abstract][Full Text] [Related]
37. A quantitative proteomics analysis of MCF7 breast cancer stem and progenitor cell populations.
Nie S; McDermott SP; Deol Y; Tan Z; Wicha MS; Lubman DM
Proteomics; 2015 Nov; 15(22):3772-83. PubMed ID: 26332018
[TBL] [Abstract][Full Text] [Related]
38. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance.
Tsou SH; Chen TM; Hsiao HT; Chen YH
PLoS One; 2015; 10(1):e0116747. PubMed ID: 25635866
[TBL] [Abstract][Full Text] [Related]
39. The Rac Inhibitor EHop-016 Inhibits Mammary Tumor Growth and Metastasis in a Nude Mouse Model.
Castillo-Pichardo L; Humphries-Bickley T; De La Parra C; Forestier-Roman I; Martinez-Ferrer M; Hernandez E; Vlaar C; Ferrer-Acosta Y; Washington AV; Cubano LA; Rodriguez-Orengo J; Dharmawardhane S
Transl Oncol; 2014 Oct; 7(5):546-55. PubMed ID: 25389450
[TBL] [Abstract][Full Text] [Related]
40. Impaired cell death and mammary gland involution in the absence of Dock1 and Rac1 signaling.
Bagci H; Laurin M; Huber J; Muller WJ; Côté JF
Cell Death Dis; 2014 Aug; 5(8):e1375. PubMed ID: 25118935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
